Phibro Animal Health (PAHC) Deferred Taxes (2013 - 2026)
Phibro Animal Health's (PAHC) quarterly Deferred Taxes came in at $3.7 million in Q1 2026, up 692.07% year-on-year from $461953.4 in Q1 2025, and down 4.66% quarter-over-quarter from $3.8 million in Q4 2025.
Phibro Animal Health (PAHC) Deferred Taxes (2013 - 2026) Analysis & Trends
Phibro Animal Health's Deferred Taxes history runs 14 years deep, the most recent figure standing at $3.7 million for Q1 2026.
- On a quarterly basis, Deferred Taxes rose 692.07% year-over-year to $3.7 million in Q1 2026; TTM through Mar 2026 was $18.0 million, a 197.58% increase from a year earlier, with the FY2025 full-year figure at -$4.9 million, up 59.48% from the prior year.
- Deferred Taxes slipped to $3.7 million in Q1 2026 per PAHC's latest filing, from $3.8 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $8.4 million in Q2 2025 and bottomed at -$7.7 million in Q4 2024.
- The 5-year median for Deferred Taxes is -$300000.0 (2024), against an average of -$609411.8.
- Across the five-year window, Deferred Taxes plunged 20600.0% in 2023 and soared 692.07% in 2026, its largest moves.
- Year by year, Deferred Taxes stood at -$108000.0 in 2022, then slumped by 3432.41% to -$3.8 million in 2023, then tumbled by 102.88% to -$7.7 million in 2024, then jumped by 149.59% to $3.8 million in 2025, then decreased by 4.66% to $3.7 million in 2026.
- Per Business Quant, the three latest PAHC Deferred Taxes figures stand at $3.7 million (Q1 2026), $3.8 million (Q4 2025), and $2.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -22.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 34.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 25.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -69.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -61.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn | 3.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.66 Mn |
| Dec 31, 2025 | 3.84 Mn |
| Sep 30, 2025 | 2.17 Mn |
| Jun 30, 2025 | 8.36 Mn |
| Mar 31, 2025 | -618,000.00 |
| Dec 31, 2024 | -7.74 Mn |
| Sep 30, 2024 | -4.88 Mn |
| Jun 30, 2024 | -5.24 Mn |
| Mar 31, 2024 | -300,000.00 |
| Dec 31, 2023 | -3.82 Mn |
| Sep 30, 2023 | -2.69 Mn |
| Jun 30, 2023 | -3.07 Mn |
| Mar 31, 2023 | 356,000.00 |
| Dec 31, 2022 | -108,000.00 |
| Sep 30, 2022 | -13,000.00 |
| Jun 30, 2022 | -686,000.00 |
| Mar 31, 2022 | 417,000.00 |
| Dec 31, 2021 | -506,000.00 |
| Sep 30, 2021 | -31,000.00 |
| Jun 30, 2021 | -2.20 Mn |